Bill Koski talks about his path to bioengineering through neurobiology research, and how the major sparked his interest in entrepreurship.
Undergrad Connor Tsuchida talks about his experience in leadership with BMES and student journal Denatured, and offers advice to prospective students.
Online Master of Pharmaceutical Bioengineering prepares working professionals to drive drug discovery, development
In this professional master's degree program, students gain cutting-edge knowledge in basic bioscience, drug discovery and pharmaceutics, and learn how to apply their expertise to market-based demands of pharmaceutical industry.
Bioengineering Outreach and Honors team adapts toys for children with disabilities at holiday toy hack event
At the TCAT Hack for Access: Holiday Toy Event on Sunday December 11, volunteers from UW and the Seattle community adapted toys for children with disabilities – just in time for the holidays!
Image: BioE Ph.D. student Molly Mollica talks with Seattle's King 5 TV about the importance [...]
A drive to engineer solutions to global health problems compelled recent Yager lab Ph.D. graduate Joshua Buser to pursue bioengineering. He aims to bring diagnostic testing to low-resource settings – and increase access to affordable health care closer to home.
Bioengineering has become a popular undergraduate major, and the cohort size has grown. New BioE 'families' seek to maintain the cohort's sense of community, and offer undergrads opportunities for leadership, mentoring.
Nuttada is developing OLA-SIMPLE, which aims to be the first instrument-free device that emulates the diagnostic capabilities of laboratory testing to provide a rapid visual readout of HIV diagnosis, viral load and drug resistance at the point of care.
College of Engineering features Bioengineers without Borders team’s project to create portable anesthesia device for developing countries
Photo: Eric Swanson and David Peeler, Bioengineers Without Borders team members and Bioengineering graduate students. A [...]
The researchers were selected for their proposal and business plan to develop a targeted drug delivery system for breast cancer which targets a specific population of tumor-promoting cells.